Luke Vargas

Less than two weeks after taking over for Justin Trudeau, Canadian Prime Minister Mark Carney has called a snap election, a vote that will revolve largely around the question of how Canada will deal with President Trump. Speaking yesterday in Ottawa, Carney said Canadians will go to the polls at the end of April.

Less than two weeks after taking over for Justin Trudeau, Canadian Prime Minister Mark Carney has called a snap election, a vote that will revolve largely around the question of how Canada will deal with President Trump. Speaking yesterday in Ottawa, Carney said Canadians will go to the polls at the end of April.

The former central banker is hoping to capitalize on momentum in the polls for his Liberal Party, which has coincided with a patriotic backlash against Trump's threats to slap tariffs on one of the U.S. 's largest trading partners or annex the country entirely. Conservative Party leader Pierre Palliev was also quick to hit the campaign trail in Toronto.

The former central banker is hoping to capitalize on momentum in the polls for his Liberal Party, which has coincided with a patriotic backlash against Trump's threats to slap tariffs on one of the U.S. 's largest trading partners or annex the country entirely. Conservative Party leader Pierre Palliev was also quick to hit the campaign trail in Toronto.

Poliev, a career politician, used populist rhetoric in building up a huge polling lead last year and has recently tried to capture some of the anti-U.S. energy in his speeches. Coming up, as markets around the world trade at near-record discounts to the U.S., even some of the most all-American investors are shifting their assets abroad. That story and more after the break.

Poliev, a career politician, used populist rhetoric in building up a huge polling lead last year and has recently tried to capture some of the anti-U.S. energy in his speeches. Coming up, as markets around the world trade at near-record discounts to the U.S., even some of the most all-American investors are shifting their assets abroad. That story and more after the break.

2025 was supposed to be the year of American exceptionalism, yet the U.S. stock market finds itself languishing, not least because investors who were all in on U.S. stocks are starting to look elsewhere. My colleague Kate Bullivan spoke to journal reporter Owen Tucker-Smith to find out where they're putting their money instead.

2025 was supposed to be the year of American exceptionalism, yet the U.S. stock market finds itself languishing, not least because investors who were all in on U.S. stocks are starting to look elsewhere. My colleague Kate Bullivan spoke to journal reporter Owen Tucker-Smith to find out where they're putting their money instead.

And DNA testing company 23andMe filed for bankruptcy last night. CEO Ann Wojcicki also stepped down from her role, but will remain on the board as she continues efforts to buy the company's assets. Those include DNA samples from more than 15 million people, which could be sold in bankruptcy proceedings.

And DNA testing company 23andMe filed for bankruptcy last night. CEO Ann Wojcicki also stepped down from her role, but will remain on the board as she continues efforts to buy the company's assets. Those include DNA samples from more than 15 million people, which could be sold in bankruptcy proceedings.

Prior to the Chapter 11 filing, California's attorney general reminded consumers in his state of their right to delete their information, a step some may scramble to take due to concerns over who could ultimately own their personal genetic data. 23andMe said any buyer would have to comply with applicable law governing consumer data.

Prior to the Chapter 11 filing, California's attorney general reminded consumers in his state of their right to delete their information, a step some may scramble to take due to concerns over who could ultimately own their personal genetic data. 23andMe said any buyer would have to comply with applicable law governing consumer data.

The company had an enterprise value of more than $6 billion as recently as 2021, but struggled to find a profitable business model. And that's it for What's News for this Monday morning. Additional sound in this episode was from Reuters. Today's show was produced by Kate Boulivant and Daniel Bach with supervising producer Sandra Kilhoff. And I'm Luke Vargas for The Wall Street Journal.

The company had an enterprise value of more than $6 billion as recently as 2021, but struggled to find a profitable business model. And that's it for What's News for this Monday morning. Additional sound in this episode was from Reuters. Today's show was produced by Kate Boulivant and Daniel Bach with supervising producer Sandra Kilhoff. And I'm Luke Vargas for The Wall Street Journal.

We will be back tonight with a new show. Until then, thanks for listening.

We will be back tonight with a new show. Until then, thanks for listening.

Hi, What's News listeners. It's Sunday, March 23rd. I'm Luke Vargas for The Wall Street Journal, and this is What's News Sunday, the show where we tackle the big questions about the biggest stories in the news by reaching out to our colleagues across the newsroom to help explain what's happening in our world.

Hi, What's News listeners. It's Sunday, March 23rd. I'm Luke Vargas for The Wall Street Journal, and this is What's News Sunday, the show where we tackle the big questions about the biggest stories in the news by reaching out to our colleagues across the newsroom to help explain what's happening in our world.

The Affordable Care Act was signed into law 15 years ago today, a bill that kicked off a sweeping overhaul of U.S. health care, expanding coverage to more than 30 million Americans via its Medicaid expansion. And after surviving three legal challenges at the Supreme Court, it's become firmly entrenched in the American healthcare system.

The Affordable Care Act was signed into law 15 years ago today, a bill that kicked off a sweeping overhaul of U.S. health care, expanding coverage to more than 30 million Americans via its Medicaid expansion. And after surviving three legal challenges at the Supreme Court, it's become firmly entrenched in the American healthcare system.